Gerresheimer AG (GXI) PT Set at €63.50 by Hauck & Aufhaeuser
Gerresheimer AG (ETR:GXI) has been assigned a €63.50 ($75.60) price objective by analysts at Hauck & Aufhaeuser in a note issued to investors on Thursday. The firm currently has a “neutral” rating on the stock.
Several other equities research analysts have also weighed in on GXI. Berenberg Bank set a €85.00 ($101.19) price objective on Gerresheimer AG and gave the stock a “buy” rating in a report on Wednesday, May 24th. J P Morgan Chase & Co set a €99.80 ($118.81) target price on Gerresheimer AG and gave the stock a “buy” rating in a research note on Wednesday, May 31st. DZ Bank AG restated a “neutral” rating on shares of Gerresheimer AG in a research note on Friday, June 9th. Commerzbank Ag set a €73.00 ($86.90) target price on Gerresheimer AG and gave the stock a “neutral” rating in a research note on Monday, June 26th. Finally, Goldman Sachs Group, Inc. (The) set a €73.00 ($86.90) target price on Gerresheimer AG and gave the stock a “neutral” rating in a research note on Friday, June 30th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of €72.99 ($86.89).
Shares of Gerresheimer AG (ETR:GXI) opened at 64.779 on Thursday. The company has a market cap of €2.03 billion and a PE ratio of 17.944. Gerresheimer AG has a 52-week low of €59.97 and a 52-week high of €79.47. The company’s 50-day moving average is €66.96 and its 200 day moving average is €71.28.
WARNING: This report was published by Daily Political and is owned by of Daily Political. If you are reading this report on another domain, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this report can be read at https://www.dailypolitical.com/2017/09/23/gerresheimer-ag-gxi-pt-set-at-63-50-by-hauck-aufhaeuser.html.
Gerresheimer AG Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.